docetaxel anhydrous has been researched along with Gastric Outlet Obstruction in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Fingerhut, A; He, ZR; Hong, HJ; Jiang, TY; Lu, AG; Ma, JJ; Zang, L; Zhang, LY; Zhao, X; Zheng, MH | 1 |
Iwasaki, W; Kichiraku, T; Kikkawa, M; Kotanagi, H; Kotanagi, K; Muto, O; Ouchi, S; Sato, K; Sawada, T | 1 |
2 other study(ies) available for docetaxel anhydrous and Gastric Outlet Obstruction
Article | Year |
---|---|
Staged laparoscopic management of locally advanced gastric cancer with outlet obstruction.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Docetaxel; Female; Fluorouracil; Gastrectomy; Gastric Bypass; Gastric Outlet Obstruction; Humans; Infusions, Intravenous; Laparoscopy; Leucovorin; Lymph Nodes; Male; Middle Aged; Neoplasm Grading; Omentum; Oxaliplatin; Retrospective Studies; Stomach Neoplasms | 2021 |
Modified administration schedule of docetaxel, cisplatin, and fluorouracil for advanced or recurrent gastric cancer with gastrointestinal stenosis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Female; Fluorouracil; Gastric Outlet Obstruction; Gastrointestinal Diseases; Humans; Intestinal Obstruction; Male; Middle Aged; Recurrence; Stomach Neoplasms; Taxoids | 2014 |